{
  "id": "repare-therapeutics-completes-acquisition-by-xenotherapeutics",
  "title": "Repare Therapeutics completes acquisition by XenoTherapeutics",
  "summary": "Repare Therapeutics Inc., a clinical‑stage precision oncology company focused on targeted cancer therapies, announced that it has completed its previously announced acquisition by XenoTherapeutics, Inc. and Xeno Acquisition Corp., a non‑profit biotechnology entity, the company said. The statutory plan of arrangement was approved by Repare shareholders in January 2026 and authorised by the Superior Court […] The post Repare Therapeutics completes acquisition by XenoTherapeutics appeared first on Longevity.Technology.",
  "url": "https://longevity.technology/news/repare-therapeutics-completes-acquisition-by-xenotherapeutics/",
  "source": "Longevity.Technology",
  "author": null,
  "category": "news",
  "publishedAt": "2026-01-30T11:31:08.000Z",
  "fetchedAt": "2026-02-04T10:49:05.819Z",
  "relevanceScore": 0.2,
  "matchedKeywords": [
    "longevity"
  ],
  "relatedProducts": [],
  "type": "web",
  "savedAt": "2026-02-04T10:49:05.891Z"
}